UNDERWRITING AGREEMENT betweenUnderwriting Agreement • January 12th, 2021 • Viveve Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
As Representative of the several Underwriters named on Schedule 1 attached hereto 590 Madison Avenue, 28th Floor New York, New York 10022
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase • January 12th, 2021 • Viveve Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____]1, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from VIVEVE MEDICAL, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Underwriting Agreement, dated January ___, 2020, between the Company and A.G.P./Alliance Global Partners, as representative of the underwriters thereunder (the “Underwriting Agreement”). This W
WARRANT AGENT AGREEMENTWarrant Agent Agreement • January 12th, 2021 • Viveve Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
This Warrant Agent Agreement made as of [___________], 2021, is between Viveve Medical, Inc., a Delaware corporation, with offices at 345 Inverness Drive South, Building B, Suite 250, Englewood, CO 80112 (the “Company”), and VStock Transfer, LLC, with offices at 18 Lafayette Place, Woodmere, New York (the “Warrant Agent”).
